2.39
                                            Schlusskurs vom Vortag:
              $2.45
            Offen:
              $2.49
            24-Stunden-Volumen:
                2.42M
            Relative Volume:
              0.66
            Marktkapitalisierung:
                $543.44M
            Einnahmen:
              -
            Nettoeinkommen (Verlust:
              $-179.82M
            KGV:
              -1.797
            EPS:
                -1.33
            Netto-Cashflow:
                $-159.16M
            1W Leistung:
              +0.00%
            1M Leistung:
              -7.00%
            6M Leistung:
                +102.54%
            1J Leistung:
              +173.55%
            Gossamer Bio Inc Stock (GOSS) Company Profile
Firmenname
                  
                      Gossamer Bio Inc
                    
                Sektor
                  Branche
                  Telefon
                  
                      (858) 684-1300
                    
                Adresse
                  
                      3115 MERRYFIELD ROW, SAN DIEGO, CA
                    
                Vergleichen Sie GOSS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV | 
|---|---|---|---|---|---|---|
| 
                         
                          
                                GOSS
                            
                             
                        Gossamer Bio Inc 
                           | 
                    2.39 | 560.76M | 0 | -179.82M | -159.16M | -1.33 | 
| 
                         
                          
                                VRTX
                            
                             
                        Vertex Pharmaceuticals Inc 
                           | 
                    426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 | 
| 
                         
                          
                                REGN
                            
                             
                        Regeneron Pharmaceuticals Inc 
                           | 
                    642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 | 
| 
                         
                          
                                ALNY
                            
                             
                        Alnylam Pharmaceuticals Inc 
                           | 
                    434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 | 
| 
                         
                          
                                ARGX
                            
                             
                        Argen X Se Adr 
                           | 
                    826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 | 
| 
                         
                          
                                INSM
                            
                             
                        Insmed Inc 
                           | 
                    186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 | 
Gossamer Bio Inc Stock (GOSS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung | 
|---|---|---|---|
| 2025-09-10 | Hochstufung | UBS | Neutral → Buy | 
| 2025-07-14 | Eingeleitet | Scotiabank | Sector Outperform | 
| 2024-06-25 | Eingeleitet | Oppenheimer | Outperform | 
| 2024-04-05 | Fortgesetzt | Wedbush | Outperform | 
| 2023-07-27 | Herabstufung | UBS | Buy → Neutral | 
| 2023-03-07 | Herabstufung | Raymond James | Outperform → Mkt Perform | 
| 2023-03-01 | Eingeleitet | Guggenheim | Neutral | 
| 2022-12-07 | Herabstufung | Barclays | Overweight → Equal Weight | 
| 2022-12-07 | Herabstufung | JP Morgan | Neutral → Underweight | 
| 2022-12-07 | Herabstufung | SMBC Nikko | Outperform → Neutral | 
| 2022-10-20 | Eingeleitet | Goldman | Buy | 
| 2022-09-21 | Eingeleitet | JP Morgan | Neutral | 
| 2022-09-19 | Eingeleitet | Wedbush | Outperform | 
| 2022-04-18 | Eingeleitet | Raymond James | Outperform | 
| 2022-04-06 | Eingeleitet | UBS | Buy | 
| 2022-01-10 | Hochstufung | SMBC Nikko | Neutral → Outperform | 
| 2021-11-09 | Fortgesetzt | Cantor Fitzgerald | Overweight | 
| 2021-09-21 | Fortgesetzt | Piper Sandler | Overweight | 
| 2020-06-29 | Eingeleitet | H.C. Wainwright | Buy | 
| 2020-04-22 | Eingeleitet | Piper Sandler | Overweight | 
| 2020-02-27 | Eingeleitet | Barclays | Overweight | 
| 2019-12-03 | Fortgesetzt | BofA/Merrill | Buy | 
| 2019-10-30 | Eingeleitet | Berenberg | Buy | 
| 2019-03-05 | Eingeleitet | Barclays | Overweight | 
| 2019-03-05 | Eingeleitet | BofA/Merrill | Buy | 
| 2019-03-05 | Eingeleitet | Evercore ISI | Outperform | 
| 2019-03-05 | Eingeleitet | SVB Leerink | Outperform | 
                    Alle ansehen
                    
                  
                Gossamer Bio Inc Aktie (GOSS) Neueste Nachrichten
Will Gossamer Bio Inc. stock recover faster than marketQuarterly Profit Report & Expert Approved Momentum Ideas - newser.com
How to use Fibonacci retracement on Gossamer Bio Inc.2025 Analyst Calls & Consistent Profit Trading Strategies - newser.com
Will Gossamer Bio Inc. (4GB) stock keep raising dividendsPortfolio Risk Summary & Stock Portfolio Risk Management - newser.com
Gossamer Bio Inc expected to post a loss of 19 cents a shareEarnings Preview - TradingView
Why Gossamer Bio Inc. (4GB) stock could outperform next yearWeekly Profit Recap & Free Long-Term Investment Growth Plans - newser.com
Is Gossamer Bio Inc. stock affected by interest rate hikes2025 Historical Comparison & Weekly Top Gainers Trade List - newser.com
Why retail investors favor Gossamer Bio Inc. stock2025 Bull vs Bear & Risk Controlled Stock Pick Alerts - newser.com
Is now a turning point for Gossamer Bio Inc.July 2025 Big Picture & Trade Opportunity Analysis - newser.com
Strategies to average down on Gossamer Bio Inc.2025 Breakouts & Breakdowns & Risk Controlled Stock Alerts - newser.com
What Fibonacci levels say about Gossamer Bio Inc. reboundJuly 2025 Fed Impact & Expert Approved Momentum Trade Ideas - newser.com
What valuation multiples suggest for Gossamer Bio Inc. stock2025 Volatility Report & AI Powered Buy/Sell Recommendations - newser.com
What Wall Street predicts for Gossamer Bio Inc. stock price2025 Institutional Moves & Real-Time Volume Analysis - newser.com
Will Gossamer Bio Inc. (4GB) stock issue positive guidancePortfolio Return Report & Growth-Oriented Investment Plans - newser.com
Can momentum traders help lift Gossamer Bio Inc.2025 Market Outlook & Capital Efficient Trade Techniques - newser.com
Is Gossamer Bio Inc. (4GB) stock nearing a technical breakoutMarket Risk Report & Free High Accuracy Swing Entry Alerts - newser.com
Is Gossamer Bio Inc. (4GB) stock supported by strong fundamentals2025 Volatility Report & Stepwise Swing Trade Plans - newser.com
Why millennials buy Gossamer Bio Inc. (4GB) stockQuarterly Profit Review & Real-Time Buy Signal Alerts - newser.com
Ranking Gossamer Bio Inc. among high performing stocks via toolsEarnings Beat & High Accuracy Buy Signal Tips - newser.com
Institutional Investors Control 62% of Gossamer Bio, Inc. (NASDAQ:GOSS) and Were Rewarded Last Week After Stock Increased 16% - 富途牛牛
Published on: 2025-10-31 05:26:53 - newser.com
Gossamer Bio (GOSS) to Release Quarterly Earnings on Thursday - MarketBeat
Does Gossamer Bio Inc. show high probability of reboundOptions Play & Free Community Supported Trade Ideas - newser.com
Using portfolio simulators with Gossamer Bio Inc. includedWeekly Loss Report & Free Fast Gain Swing Trade Alerts - newser.com
Why Gossamer Bio Inc. stock remains undervaluedJuly 2025 Drop Watch & Fast Entry High Yield Stock Tips - newser.com
Gossamer Bio, Inc. (NASDAQ:GOSS) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Finanzdaten der Gossamer Bio Inc-Aktie (GOSS)
Umsatz
Nettogewinn
Free Cashflow
ENV
        In Yahoo öffnen
        |
        In Google öffnen
            |
            In Finviz öffnen
        |
        In MarketWatch öffnen
            |
            Öffnen Sie in EDGAR    
        |
        Offen in Reuters
    
    
                Kapitalisierung:
                 
                  | 
                Volumen (24h):